Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Heart Rhythm Society Finalizes Recommendations, Urges Postmarket Reform

This article was originally published in The Gray Sheet

Executive Summary

The Heart Rhythm Society's final recommendations for industry, FDA and physicians on handling malfunctions of implantable heart devices, issued Sept. 28, "are only the beginning of what needs to happen," said HRS President Dwight Reynolds, MD

You may also be interested in...



Heart Rhythm Experts Release New Pacer/ICD Lead Management Guidelines

New recommendations from leading heart experts call on physicians, device manufacturers and FDA to do a better job monitoring and managing the safety of pacemaker and implantable defibrillator leads

Heart Rhythm Experts Release New Pacer/ICD Lead Management Guidelines

New recommendations from leading heart experts call on physicians, device manufacturers and FDA to do a better job monitoring and managing the safety of pacemaker and implantable defibrillator leads

Harvard’s Maisel Builds An Institute To Spotlight, Explain Device Risks

Harvard cardiologist William Maisel has been an important moderating voice during some of the device industry's most controversial moments in recent years. Of late, he has become a more vocal critic of industry and CDRH and is now building a non-profit institute to help fill what he sees as substantial gaps in data collection and public communication on device safety issues

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel